Benjamin Looker - Net Worth and Insider Trading

Benjamin Looker Net Worth

The estimated net worth of Benjamin Looker is at least $164,816 dollars as of 2024-05-01. Benjamin Looker is the General Counsel of Esperion Therapeutics Inc and owns about 83,663 shares of Esperion Therapeutics Inc (ESPR) stock worth over $164,816. Details can be seen in Benjamin Looker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Benjamin Looker has not made any transactions after 2023-04-19 and currently still holds the listed stock(s).

Transaction Summary of Benjamin Looker

To

Benjamin Looker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin Looker owns 1 companies in total, including Esperion Therapeutics Inc (ESPR) .

Click here to see the complete history of Benjamin Looker’s form 4 insider trades.

Insider Ownership Summary of Benjamin Looker

Ticker Comapny Transaction Date Type of Owner
ESPR Esperion Therapeutics Inc 2023-04-19 General Counsel

Benjamin Looker Latest Holdings Summary

Benjamin Looker currently owns a total of 1 stock. Benjamin Looker owns 83,663 shares of Esperion Therapeutics Inc (ESPR) as of April 19, 2023, with a value of $164,816.

Latest Holdings of Benjamin Looker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ESPR Esperion Therapeutics Inc 2023-04-19 83,663 1.97 164,816

Holding Weightings of Benjamin Looker


Benjamin Looker Form 4 Trading Tracker

According to the SEC Form 4 filings, Benjamin Looker has made a total of 2 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Esperion Therapeutics Inc is the sale of 1,290 shares on April 19, 2023, which brought Benjamin Looker around $1,638.

Insider Trading History of Benjamin Looker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benjamin Looker Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Benjamin Looker Ownership Network

Ownership Network List of Benjamin Looker

No Data

Ownership Network Relation of Benjamin Looker


Benjamin Looker Owned Company Details

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Benjamin Looker is the General Counsel of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Benjamin Looker made 2 insider transaction in Esperion Therapeutics Inc (ESPR) with a net sale of 7,637. Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Esperion Therapeutics Inc Insider Transactions

No Available Data

Benjamin Looker Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin Looker. You might contact Benjamin Looker via mailing address: C/o Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga A6 L5l 1j9.

Discussions on Benjamin Looker

No discussions yet.